Patents, pandemics and pricing: a peek at the top drug from every big pharma
PharmaVoice
AUGUST 22, 2022
A look at how the biggest pharma companies in the world and their top-selling drugs fared in the first half of the year.
Mon.Aug 22, 2022
278 
Trial Results Suggest Metformin Is Effective at Reducing Odds of Serious COVID-19 Outcomes
Pharmacy Times
AUGUST 22, 2022
University of Minnesota Medical School Analysis shows comparison with fluvoxamine and ivermectin in a double-blinded, placebo-controlled, randomized study.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
First 90 Days: Agios Pharmaceuticals’ Brian Goff
PharmaVoice
AUGUST 22, 2022
The rare disease veteran and first-time CEO is bringing his expertise to the company as it launches the first FDA-approved treatment for pyruvate kinase (PK) deficiency.
Frazier PhRMA Scholarship awarded to four college-bound students in Philadelphia and DC
PhRMA
AUGUST 22, 2022
The Kenneth C. Frazier PhRMA Scholars Program is going strong in 2022—and we are expanding our horizons to a new city. This summer, we are thrilled to announce four new recipients: Arianna Camacho-Mendez and Axel Orellana from Washington, D.C.; and Michelle Tanujaya and Jackie Zhao, our first students from Philadelphia. Congratulations to these amazing scholars!
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Flipping the script to disrupt, redefine and accelerate the patient care journey
PharmaVoice
AUGUST 22, 2022
A new, digitally innovative care model empowers patients and expedites their access to treatment.
FDA Clears Omnipod 5 Automated Insulin Delivery System for Type 1 Diabetes Patients 2 Years of Age and Older
Pharmacy Times
AUGUST 22, 2022
Omnipod 5 is an automated, tubeless insulin dispensing system that allows for continuous infusion and bolus dosing as needed.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Lack of Awareness of Omicron Variant Infectious Status in More than Half of Adults Contributes to High Transmission Rates
Pharmacy Times
AUGUST 22, 2022
Overall low awareness of the Omicron variant infection contributed to high transmission rates and rapid spread of SARS-CoV-2 in communities.
American Kidney Fund launches resources to engage patients of color
Outsourcing Pharma
AUGUST 22, 2022
The group has introduced a downloadable guide, interactive quiz, and other tools to inform patients from underrepresented communities about trial participation.
AHA Statement Outlines Most Common Symptoms of 6 Cardiovascular Disease
Pharmacy Times
AUGUST 22, 2022
The American Heart Association includes 6 conditions and indicates that men’s and women’s experiences may differ.
Is it time to start rethinking mobile clinical trial apps?
Outsourcing Pharma
AUGUST 22, 2022
A leader from the trial financial management specialist suggests apps used in trials could be adjusted to better suit patients, sites and other stakeholders.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
FDA Grants Emergency Use Authorization for Novavax COVID-19 Vaccine in Adolescents Aged 12 Through 17
Pharmacy Times
AUGUST 22, 2022
The announcement marks the first protein-based COVID-19 vaccine authorized in the United States for this patient population.
Medication Safety Quiz 2022
OctariusRx
AUGUST 22, 2022
The 2022 version of the OctariusRx medication safety quiz is about to be released. Ongoing education and assessments of staff medication management competency are standards of good practice. Medication competency and your consultant pharmacist are two things that should go hand-in-hand. How are you assessing your staff? Use our tool to help enhance patient safety and satisfy the regulatory requirement.
Court Reviews Regulatory Status of Homeopathic Drug Products
Pharmacy Times
AUGUST 22, 2022
Decision in favor of FDA partially clarifies a somewhat gray area of the law regarding medications.
New study use musical tests for early detection of cognitive decline
Pharma Times
AUGUST 22, 2022
Researchers at Tel Aviv University used a portable brain activity-measuring device to detect cognitive decline in older people
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Trends in Oncology Pharmacy Will Drive the Market Beyond 2022
Pharmacy Times
AUGUST 22, 2022
New drugs, virtual care, and a patient-focused approach are key during this period of transformation.
Jazz Pharmaceuticals’ epilepsy drug advances into phase 3 trial
Pharma Times
AUGUST 22, 2022
Epidiolex may ease symptoms associated with Doose syndrome, a rarer type of childhood-onset epilepsy
Handling Narcissism in the Workforce and Spiritual Bankruptcy
Pharmacy Times
AUGUST 22, 2022
Narcissistic leaders have a negative impact on the culture of their organization as their conduct and management style induces fear.
Digital health firm Akili raises $163m in Nasdaq listing
pharmaphorum
AUGUST 22, 2022
Akili has started trading publicly today, raising $163 million as a result of its merger with a blank cheque company, saying the cash injection will help fund further development of its video-game based digital therapeutics (DTx). The company made its debut on the Nasdaq on Friday under the AKLI ticker with a starting share price of $9.65, and made swift gains, more than doubling to $20-plus in trading today having spiked as high as $36.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Daily OTC Pearl: Aobbiy
Pharmacy Times
AUGUST 22, 2022
Aobbiy is a lung expansion and mucus relief device that aids in mucus removal to help clear the airway.
Tech Innovations: August 2022
Outsourcing Pharma
AUGUST 22, 2022
This monthâs news on technology, partnerships, expansions, and more includes items from IQVIA, Almac Group, Signant Health, Lonza, and other key companies.
Daily Medication Pearl: Ceftolozane and Tazobactam (Zerbaxa)
Pharmacy Times
AUGUST 22, 2022
Zerbaxa is a combination of ceftolozane, a cephalosporin antibacterial, and tazobactam, a beta-lactamase inhibitor.
API nitrosamines: method sensitivity issues
European Pharmaceutical Review
AUGUST 22, 2022
HARDLY A DAY goes by without mention of a newly emerging active pharmaceutical ingredient (API) nitrosamine, eg, nitrosamine propranolol. 1 This has led to a great deal of pre-competitive data sharing. For instance, Lhasa initiated a Nitrites in Excipients database to facilitate risk assessment of drug products, which was recently published. 2,3 The database categorises excipients thus: 1) excipients show varying nitrite contents with pronounced batch-to-batch variance, 2) the nitrite impact is
NACDS Total Store Expo 2022 Promises to Bring Together Pharmacy, Retail Stakeholders
Pharmacy Times
AUGUST 22, 2022
The Total Store Expo is taking place in Boston from August 27 through 29, 2022.
WHO recommends antibody therapies to treat Ebola virus
Pharmaceutical Technology
AUGUST 22, 2022
The World Health Organization (WHO) has made new recommendations for the usage of two monoclonal antibodies to treat the Ebola virus in its first published guideline. mAb114 (Ansuvimab; Ebanga) and REGN-EB3 (Inmazeb) are the two monoclonal antibody treatments recommended by the WHO. The health agency urged the global community to boost access to these lifesaving therapies.
Rx Product News: August 2022
Pharmacy Times
AUGUST 22, 2022
This month's rx product news features Skyrizi (AbbVie), Myfembree (Myovant Sciences, Pfizer), and Dupixent (Regeneron Pharmaceuticals).
Vaccine Scheduler
PioneerRx
AUGUST 22, 2022
As cold and flu season approaches, many patients are taking precautions and getting the vaccinations they need to stay healthy. This includes signing up for their.
Expert Discusses Drug Diversion in the Pharmacy
Pharmacy Times
AUGUST 22, 2022
Jake Nichols, PharmD, CEO, president, and co-founder of Renovo Health, discusses his experience with drug diversion and addiction.
American Oncology Network Ranks No. 107 on the 2022 Inc. 5000 Annual List
Pharmacy Times
AUGUST 22, 2022
AON receives ranking no. 107 among America’s fastest-growing private companies and no. eight among health services.
Motivational Interviewing for Independent Pharmacy, Part 1
PioneerRx
AUGUST 22, 2022
One of the many ways independent pharmacies increase the value of the healthcare scene is their patient relationships and interactions.
Business Spend management for Today and Tomorrow: Creating a Scalable Foundation for Growth
PharmExec
AUGUST 22, 2022
Tue, Aug 23, 2022 1:00 PM EDT Hear how Werewolf Therapeutics successfully transformed its spend management processes by driving efficiencies; increasing savings; and implementing efficient, compliant systems on a scalable foundation for growth. How do procurement and finance leaders at biopharma companies plan for a future that has unknowns and uncertainty?
One Door Shuts, and Another Opens
PioneerRx
AUGUST 22, 2022
The Independent Pharmacy industry is constantly changing, sometimes faster than we are prepared for.
Porton raises funds for gene and cell therapy CDMO platforms expansion
Pharmaceutical Technology
AUGUST 22, 2022
Porton Advanced Solutions has raised $80m in a Series B funding round to expand its end-to-end gene and cell therapy (GCT) contract development and manufacturing organisation (CDMO) platforms. Merchant Health, a healthcare private equity (PE) fund of China Merchants Groups, led the financing round together with its sister fund China Merchants Capital and China Merchants Securities Investments.
Let's personalize your content